You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 19, 2024

COGENTIN Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Cogentin, and when can generic versions of Cogentin launch?

Cogentin is a drug marketed by Epic Pharma Llc and Merck and is included in two NDAs.

The generic ingredient in COGENTIN is benztropine mesylate. There are seven drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the benztropine mesylate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Cogentin

A generic version of COGENTIN was approved as benztropine mesylate by PLIVA on August 10th, 1988.

  Try a Trial

Summary for COGENTIN
Drug patent expirations by year for COGENTIN
Drug Prices for COGENTIN

See drug prices for COGENTIN

Recent Clinical Trials for COGENTIN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Tanta UniversityPhase 2/Phase 3
University of California, San DiegoPhase 2
National Institute of Mental Health (NIMH)Phase 4

See all COGENTIN clinical trials

US Patents and Regulatory Information for COGENTIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Epic Pharma Llc COGENTIN benztropine mesylate INJECTABLE;INJECTION 012015-001 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Merck COGENTIN benztropine mesylate TABLET;ORAL 009193-002 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Merck COGENTIN benztropine mesylate TABLET;ORAL 009193-004 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Merck COGENTIN benztropine mesylate TABLET;ORAL 009193-003 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.